文献速递神经肿瘤

低级别胶质瘤中5-ALA诱导原卟啉IX的实时荧光动力学

Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma.
PubMed 文献 · J Neurosurg · 2021-06-18

本研究纳入25例疑似高级别胶质瘤的II级胶质瘤患者,术前行5-ALA(20 mg/kg)给药,利用高光谱相机测量肿瘤组织的荧光强度与原卟啉IX浓度。发现荧光组织中原卟啉IX荧光峰值出现在给药后7-8小时,且18F-FET PET摄取与Ki-67/MIB-1指数独立预测荧光。

要点

  • 低级别胶质瘤中5-ALA诱导的荧光峰值在给药后7-8小时,提示给药时机需调整。
  • 18F-FET PET摄取和Ki-67/MIB-1指数可独立预测荧光。
  • 钆增强、ADC细胞密度与荧光相关,但1p/19q共缺失无显著关联。

核心结论

  • 低级别胶质瘤中5-ALA诱导的PpIX荧光峰值出现在给药后7-8小时,与高级别胶质瘤类似。
  • 18F-FET PET摄取和Ki-67/MIB-1指数独立预测荧光。

研究设计与样本

  • 5-ALA按20 mg/kg体重术前4小时给药,高光谱相机测量荧光强度与PpIX浓度。

主要发现

  • 荧光组织荧光强度和PpIX浓度峰值在给药后7-8小时, regardless of MRI钆增强。
  • 钆增强(p=0.008)、Ki-67/MIB-1指数(p<0.001)、18F-FET PET摄取比(p=0.004)和ADC-based肿瘤细胞密度(p=0.017)在荧光与非荧光组织间差异显著。
  • 1p/19q共缺失在荧光与非荧光组织间无显著差异。
  • 逻辑回归显示18F-FET PET摄取和Ki-67/MIB-1指数独立与荧光相关。

关键数值与推荐

  • 5-ALA剂量20 mg/kg体重,术前4小时给药。
  • 荧光峰值时间:给药后7-8小时。
  • 荧光与非荧光组织比较:钆增强p=0.008,Ki-67/MIB-1指数p<0.001,18F-FET PET摄取比p=0.004,ADC-based肿瘤细胞密度p=0.017。

临床怎么用

  • 对于低级别胶质瘤,若使用5-ALA引导切除,应考虑在给药后7-8小时进行手术以优化荧光检测。
  • 18F-FET PET摄取和Ki-67/MIB-1指数可帮助预测荧光,辅助患者选择。

局限性

  • 仅纳入II级胶质瘤且影像无法完全排除高级别胶质瘤的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: 5-Aminolevulinic acid (5-ALA) induces fluorescence in high-grade glioma (HGG), which is used for resection. However, the value of 5-ALA-induced fluorescence in low-grade glioma (LGG) is unclear. Time dependency and time kinetics have not yet been investigated. The purpose of this study was to investigate real-time kinetics of protoporphyrin IX (PpIX) in LGG based on hyperspectral fluorescence-based measurements and identify factors that predict fluorescence. METHODS: Patients with grade II gliomas and imaging from which HGGs could not be completely ruled out received 5-ALA at 20 mg/kg body weight 4 hours prior to surgery. Fluorescence intensity (FI) and PpIX concentration (CPpIX) were measured in tumor tissue utilizing a hyperspectral camera. Apparent diffusion coefficient (ADC)-based tumor cell density, Ki-67/MIB-1 index, chromosomal 1p/19q codeletion, and 18F-fluoroethyl-l-tyrosine (18F-FET) PET values and their role for predicting fluorescence were evaluated. RESULTS: Eighty-one biopsies from 25 patients were included. Tissues with fluorescence demonstrated FI and CPpIX maxima between 7 and 8 hours after administration. When visible fluorescence was observed, peaks of FI and CPpIX were observed within this 7- to 8-hour time frame, regardless of any MRI gadolinium contrast enhancement. Gadolinium enhancement (p = 0.008), Ki-67/MIB-1 index (p < 0.001), 18F-FET PET uptake ratio (p = 0.004), and ADC-based tumor cellularity (p = 0.017) significantly differed between fluorescing and nonfluorescing tissue, but not 1p/19q codeletions. Logistic regression demonstrated that 18F-FET PET uptake and Ki-67/MIB-1 index were independently related to fluorescence. CONCLUSIONS: This study reports a fluorescence-based assessment of CPpIX in human LGG tissues related to 18F-FET PET uptake and Ki-67/MIB-1. As in HGGs, fluorescence in LGGs peaked between 7 and 8 hours after 5-ALA application, which has consequences for the timing of administration.

来源:J Neurosurg,查看原文。版权归原作者所有。

引用

  1. Kaneko S, Suero Molina E, Sporns P, et al. Fluorescence real-time kinetics of protoporphyrin IX after 5-ALA administration in low-grade glioma. J Neurosurg. 2021. PMID: 34144512. doi:10.3171/2020.10.JNS202881

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。